Literature DB >> 19944552

Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment.

W van Gijn1, P Krijnen, V E P P Lemmens, M den Dulk, H Putter, C J H van de Velde.   

Abstract

BACKGROUND: In the Netherlands, the Total Mesorectal Excision (TME) surgical technique for rectal cancer was introduced together with pre-operative radiotherapy in a quality controlled manner within the framework of the TME trial (1996-1999). The aim of this study is to examine the effects of the structural changes in rectal cancer care on survival compared to colon cancer for patients treated before, during and after the TME trial.
METHOD: We compared overall survival of all patients with curatively resected colon (n = 15,266) and rectal cancer (n = 5839) in the regions of Comprehensive Cancer Centres South and West between 1990 and 2005, adjusting for prognostic variables.
RESULTS: In the pre-trial period, rectal cancer had a significant lower survival compared to colon cancer (HR 1.248, P < 0.01). However, in the post-trial period, survival after rectal cancer was similar to colon cancer (HR 0.987, n.s.).
CONCLUSION: Although survival improved significantly for both colon and rectal cancer in the last 15 years, the substantially worse results after rectal cancer have been eliminated. This study shows the lasting effects that structural surgical training and quality assurance can have on survival outcome. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19944552     DOI: 10.1016/j.ejso.2009.10.010

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

1.  Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades.

Authors:  Joern Fischer; Fischer Joern; Gunter Hellmich; Hellmich Gunter; Thomas Jackisch; Jackisch Thomas; Erik Puffer; Puffer Erik; Jörg Zimmer; Zimmer Jörg; Dorothea Bleyl; Bleyl Dorothea; Thomas Kittner; Kittner Thomas; Helmut Witzigmann; Witzigmann Helmut; Sigmar Stelzner; Stelzner Sigmar
Journal:  Int J Colorectal Dis       Date:  2015-04-29       Impact factor: 2.571

2.  Chronological improvement in survival following rectal cancer surgery: a large-scale, single-center study.

Authors:  Jong Lyul Lee; Chang Sik Yu; Chan Wook Kim; Yong Sik Yoon; Seok-Byung Lim; Jin Cheon Kim
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

3.  Effect of angiogenesis inhibitor SU6668 in combination with 5-Fu on liver metastasis from transplantation tumors of human colorectal cancer in nude mice.

Authors:  Yunfei Ge; Yinlu Ding; Jianliang Zhang; Zhanyuan Li; Zhaoting Li
Journal:  Int J Clin Exp Med       Date:  2014-10-15

4.  Influence of age on variation in patterns of care in patients with rectal cancer in Catalonia (Spain).

Authors:  R Vernet; J M Borras; L Aliste; M Antonio; A Guarga; P Manchon-Walsh
Journal:  Clin Transl Oncol       Date:  2018-05-15       Impact factor: 3.405

5.  2010 SSO John Wayne clinical research lecture: rectal cancer outcome improvements in Europe: population-based outcome registrations will conquer the world.

Authors:  W van Gijn; C J H van de Velde
Journal:  Ann Surg Oncol       Date:  2010-09-16       Impact factor: 5.344

6.  Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.

Authors:  Evaghelos Xynos; Nikolaos Gouvas; Charina Triantopoulou; Paris Tekkis; Louiza Vini; Maria Tzardi; Ioannis Boukovinas; Nikolaos Androulakis; Athanasios Athanasiadis; Christos Christodoulou; Evangelia Chrysou; Christos Dervenis; Christos Emmanouilidis; Panagiotis Georgiou; Ourania Katopodi; Panteleimon Kountourakis; Thomas Makatsoris; Pavlos Papakostas; Demetris Papamichael; Georgios Pentheroudakis; Ioannis Pilpilidis; Joseph Sgouros; Vassilios Vassiliou; Spyridon Xynogalos; Nikolaos Ziras; Niki Karachaliou; Odysseas Zoras; Christos Agalianos; John Souglakos
Journal:  Ann Gastroenterol       Date:  2016 Jan-Mar

7.  Loss of coxsackie and adenovirus receptor expression in human colorectal cancer: A potential impact on the efficacy of adenovirus-mediated gene therapy in Chinese Han population.

Authors:  Ying-Yu Ma; Xiao-Jun Wang; Yong Han; Gang Li; Hui-Ju Wang; Shi-Bing Wang; Xiao-Yi Chen; Fan-Long Liu; Xiang-Lei He; Xiang-Min Tong; Xiao-Zhou Mou
Journal:  Mol Med Rep       Date:  2016-07-21       Impact factor: 2.952

8.  Influences of hospital information systems, indicator data collection and computation on reported Dutch hospital performance indicator scores.

Authors:  Helen A Anema; Job Kievit; Claudia Fischer; Ewout W Steyerberg; Niek S Klazinga
Journal:  BMC Health Serv Res       Date:  2013-06-12       Impact factor: 2.655

9.  Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

Authors:  Evaghelos Xynos; Paris Tekkis; Nikolaos Gouvas; Louiza Vini; Evangelia Chrysou; Maria Tzardi; Vassilis Vassiliou; Ioannis Boukovinas; Christos Agalianos; Nikolaos Androulakis; Athanasios Athanasiadis; Christos Christodoulou; Christos Dervenis; Christos Emmanouilidis; Panagiotis Georgiou; Ourania Katopodi; Panteleimon Kountourakis; Thomas Makatsoris; Pavlos Papakostas; Demetris Papamichael; George Pechlivanides; Georgios Pentheroudakis; Ioannis Pilpilidis; Joseph Sgouros; Charina Triantopoulou; Spyridon Xynogalos; Niki Karachaliou; Nikolaos Ziras; Odysseas Zoras; John Souglakos
Journal:  Ann Gastroenterol       Date:  2016 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.